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Women aged 35-79 years scheduled for an explorative laparotomy or laparoscopy because of suspicion of an ovarian tumor were requested to participate in the study with blood and tissue samples and a personal interview from 16 gynecological departments in Denmark (municipalities of Copenhagen and Frederiksberg as well as the counties of Copenhagen, Frederiksberg, Roskilde, Western Zealand, Funen, Southern Jutland, and Northern Jutland). To ensure that all eligible cases in the study area were included the study database was linked to the Danish Cancer Registry every second month. If a woman was registered in the Danish Cancer Registry with ovarian cancer but had not primarily been included in the study, she was contacted by letter and asked to particpiate in the study.
Controls from the general female population, 35 to 79 years of age in the study area, were drawn by means of the computerized Civil Registration System (all inhabitants in Denmark have a unique personal identification number, which is registered in the Civil Registration System). 
Case subjects were identified by use of a rapid-reporting system in which staff visited pathology departments and hospital tumor registrars of all 32 Connecticut hospitals at 2-4 week intervals. Records were also obtained for Connecticut residents receiving care in major cancer referral centers in adjacent states, and the Connecticut Tumor Registry was queried to identify any missed cases from the hospitals information.
Controls under age 65 were identified by list-based random-digit dialing (RDD) methods. To improve participation, sampled telephone numbers found to have addresses in reverse telephone directories were mailed study introduction letters prior to initial RDD contact. Controls 65 years of age and over initially were randomly chosen from rosters of the residents of Connecticut obtained from the Health Care Financing Administration, and later were identified by the same RDD methods as were used for the younger controls. All case subjects had telephone numbers found within 1+residential blocks which validated the sampling frame of the RDD controls.
Cases were identified through the Cancer Surveillance System (CSS), a population-based registry that is part of the Surveillance, Epidemiology, and End Results (SEER) program of the U.S. National Cancer Institute.
Controls were selected by RDD using the two-stage Waksberg-Mitofsky method with a clustering factor of 5 residences per sampling unit. We used a stratified sampling design that apportioned controls into 5-year age categories, 1-year calendar intervals, and two county strata (consisting of the urban three counties encompassing Seattle and the more rural 10 surrounding counties), according to the anticipated distribution of these characteristics among women with invasive epithelial ovarian cancer.
Ovarian cancer cases were identified through the rapid-reporting systems of the statewide Hawaii Tumor Registry and the Los Angeles county Cancer Surveillance Program.
Control subjects were randomly selected from participants in an annual survey of representative households in Hawaii and by random-digit dialing in Los Angeles, and supplemented with women ≥ 65 years obtained through random sampling of lists provided by the Health Care Financing Administration.
Recruitment goal was all incident incident cases in the three catchment areas, aged 25+, with primary epithelial ovarian cancer, peritoneal cancer, cancer of the fallopian tube and/or endometrial cancer diagnosed within 9 months of recruitment. Cases were identified through a variety of sources including physician offices, cancer registries and pathology databases. Hospital registries were searched and active surveillance of practices was also used. Cases were identified through the North Carolina Central Cancer Registry by using rapid case ascertainment in a 48 county region of NC. Pathology reports for ovarian cancer cases were forwarded to the Central Cancer Registry and then to the study office within two months of diagnosis.
Controls from the same 48-county region were identified by using random digit dialing. NEC 51·2±12·7 / 50·9±12·8 0 (0·0%) / 0 (0·0%) 4 (0·4%) / 1 (0·1%) Cases were identified through statewide cancer registries and hospital tumor boards in eastern Massachsetts and New Hampshire.
Controls were identified from same regions using a combination of random digit dailing, drivers' license lists, and town resident lists (called townbooks).
Cases were identified through the California Cancer Registry by using rapid case ascertainment in Orange and San Diego counties. Pathology reports for ovarian cancer cases were forwarded to study coordinators.
Controls were identified by using random digit dialing from Orange and San Diego counties. USC 54·3±13·2 / 53·2±13·0 3 (0·2%) / 0 (0·0%) 0 (0·0%) / 0 (0·0%) Cases were identified through the Los Angeles County Cancer Surveillance Program (part of SEER) by rapid case ascertainment.
Neighborhood controls were identifying using a well-defined algorithm or for cases >65 for whom a neighborhood control could not be identified, a random sample from Health Care Financing Administration was used.
* Includes 99 cases for whom no questionnaire data were provided (ie. only a blood sample was provided) 
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